Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A21112 | 25533004 | Nutrients | Does vitamin C deficiency promote fatty liver disease development? | 2014 | Details |
A21126 | 25526792 | BMJ Open | Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes. | 2014 | Details |
A21138 | 25521620 | Obesity (Silver Spring) | Earlier menarche is associated with fatty liver and abdominal ectopic fat in midlife, independent of young adult BMI: The CARDIA study. | 2014 | Details |
A21139 | 25521607 | Aliment Pharmacol Ther | The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic. | 2014 | Details |
A21143 | 25516477 | Metabolism | The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. | 2014 | Details |
A21144 | 25516385 | J Gastroenterol | The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
A21146 | 25514916 | Rev Recent Clin Trials | Non alcoholic fatty liver: epidemiology and natural history. | 2014 | Details |
A21149 | 25514913 | Rev Recent Clin Trials | Orthotopic liver transplantation in non-alcoholic fatty liver disease patients. | 2014 | Details |
A21150 | 25514912 | Rev Recent Clin Trials | Use of liver breath tests to assess severity of nonalcoholic fatty liver disease. | 2014 | Details |
A21151 | 25514911 | Rev Recent Clin Trials | Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis. | 2014 | Details |
A21157 | 25514415 | Int J Mol Sci | Irisin, a link among fatty liver disease, physical inactivity and insulin resistance. | 2014 | Details |
A21159 | 25513983 | Menopause | Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. | 2015 | Details |
A21161 | 25512797 | World J Diabetes | Nonalcoholic steatohepatitis and insulin resistance in children. | 2014 | Details |
A21163 | 25512222 | BMC Gastroenterol | Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects. | 2014 | Details |
A21164 | 25510350 | Clin Endocrinol (Oxf) | Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. | 2015 | Details |
A21165 | 25509904 | Ter Arkh | [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease]. | 2014 | Details |
A21166 | 25509888 | Ter Arkh | [Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity]. | 2014 | Details |
A21167 | 25506780 | JAMA Pediatr | Nonalcoholic fatty liver disease: a challenge for pediatricians. | 2015 | Details |
A21171 | 25502558 | PLoS One | A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet. | 2014 | Details |
A21176 | 25500721 | J Hepatol | Age at menarche and non-alcoholic fatty liver disease. | 2014 | Details |
A21183 | 25495373 | Liver Int | ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity. | 2015 | Details |
A21184 | 25493326 | Can J Physiol Pharmacol | The CBS/CSE system: a potential therapeutic target in NAFLD? | 2015 | Details |
A21185 | 25493023 | World J Gastroenterol | Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. | 2014 | Details |
A21187 | 25492998 | World J Gastroenterol | Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. | 2014 | Details |
A21188 | 25492997 | World J Gastroenterol | Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. | 2014 | Details |
A21190 | 25492154 | Zhonghua Liu Xing Bing Xue Za Zhi | [Relations between nonalcoholic fatty liver disease and metabolic syndrome]. | 2014 | Details |
A21191 | 25491010 | Eur J Intern Med | The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. | 2014 | Details |
A21196 | 25485911 | Nat Med | Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. | 2014 | Details |
A21197 | 25484079 | Autophagy | Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies. | 2014 | Details |
A21205 | 25479248 | Nutrients | The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
A21216 | 25474087 | Int J Mol Sci | Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease. | 2014 | Details |
A21217 | 25473159 | World J Gastroenterol | Gut microbiota and metabolic syndrome. | 2014 | Details |
A21219 | 25470627 | Diabetes Metab Syndr | The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. | 2013 | Details |
A21222 | 25469977 | J Gastroenterol Hepatol | Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals. | 2015 | Details |
A21225 | 25469068 | J Korean Med Sci | Comparison between a pediatric health promotion center and a pediatric obesity clinic in detecting metabolic syndrome and non-alcoholic fatty liver disease in children. | 2014 | Details |
A21226 | 25469019 | World J Gastroenterol | Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. | 2014 | Details |
A21228 | 25469014 | World J Gastroenterol | Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. | 2014 | Details |
A21229 | 25469013 | World J Gastroenterol | Obesity, fatty liver disease and intestinal microbiota. | 2014 | Details |
A21230 | 25468829 | Int J Obes (Lond) | Fetuin-A: a novel link between obesity and related complications. | 2014 | Details |
A21240 | 25460293 | Horm Mol Biol Clin Investig | Nutrition: a promising route for prevention and management of obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
A21241 | 25460228 | Curr Opin Pharmacol | Transgenerational effects of obesogens and the obesity epidemic. | 2014 | Details |
A21243 | 25459558 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants. | 2014 | Details |
A21247 | 25456868 | Am J Cardiol | Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk. | 2014 | Details |
A21255 | 25453513 | J Med Food | Green Tea Lowers Hepatic COX-2 and Prostaglandin E2 in Rats with Dietary Fat-Induced Nonalcoholic Steatohepatitis. | 2014 | Details |
A21256 | 25452862 | BMJ Open Diabetes Res Care | Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. | 2014 | Details |
A21258 | 25451038 | Obesity (Silver Spring) | A dietary phytochemical blend prevents liver damage associated with adipose tissue mobilization in ovariectomized rats. | 2014 | Details |
A21259 | 25450719 | J Hepatol | Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine. | 2014 | Details |
A21263 | 25450212 | J Hepatol | Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity. | 2014 | Details |
A21268 | 25445436 | Life Sci | Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice. | 2014 | Details |
A21269 | 25445398 | J Hepatol | TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess. | 2014 | Details |
A21270 | 25445395 | J Hepatol | Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. | 2014 | Details |
A21273 | 25443068 | Surg Obes Relat Dis | Prevalence and characteristics of individuals without diabetes and hypertension who underwent bariatric surgery: lessons learned about metabolically healthy obese. | 2014 | Details |
A21274 | 25440222 | J Nutr Biochem | Pathophysiological basis for compromised health beyond generations: role of maternal high-fat diet and low-grade chronic inflammation. | 2014 | Details |
A21279 | 25436098 | Gastroenterol Hepatol Bed Bench | Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis. | 2014 | Details |
A21282 | 28664097 | Integr Med Res | Practical approaches to the nutritional management of nonalcoholic fatty liver disease. | 2014 | Details |
A21283 | 27356367 | Bull Acad Natl Med | [Metabolic syndrome, non alcoholic hepatic steatopathy and hepatocellular carcinoma: so dangerous liaisons]. | 2014 | Details |
A21284 | 27356366 | Bull Acad Natl Med | [Not Available]. | 2014 | Details |
A21285 | 25433160 | J Hepatol | Roles of alcohol consumption in fatty liver: a longitudinal study. | 2014 | Details |
A21287 | 25433106 | Nutr Hosp | Vitamin D levels and bone turnover markers are not related to non-alcoholic fatty liver disease in severely obese patients. | 2014 | Details |
A21288 | 25430922 | Pharm Biol | A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation. | 2014 | Details |
A21295 | 25427907 | Adv Exp Med Biol | Understanding the tumor suppressor PTEN in chronic alcoholism and hepatocellular carcinoma. | 2015 | Details |
A21299 | 25426570 | J Hypertens | The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: findings from a cross-sectional study. | 2015 | Details |
A21300 | 25422863 | Biochem J | Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase C-dependent mechanism. | 2015 | Details |
A21309 | 25415189 | PLoS One | Transcriptome analysis on the inflammatory cell infiltration of nonalcoholic steatohepatitis in bama minipigs induced by a long-term high-fat, high-sucrose diet. | 2014 | Details |
A21310 | 25414939 | Postgrad Med | Diabetes mellitus as a novel risk factor for gastrointestinal malignancies. | 2014 | Details |
A21312 | 25413450 | Metab Brain Dis | Low-grade chronic inflammation induces behavioral stereotypy in rats. | 2014 | Details |
A21317 | 25411646 | J Clin Med | Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease. | 2014 | Details |
A21323 | 25405502 | J Clin Endocrinol Metab | Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes. | 2014 | Details |
A21325 | 25404857 | Ther Clin Risk Manag | Acceleration training for managing nonalcoholic fatty liver disease: a pilot study. | 2014 | Details |
A21329 | 25401691 | Nat Med | The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. | 2014 | Details |
A21332 | 25400437 | World J Gastroenterol | Liver transplantation and non-alcoholic fatty liver disease. | 2014 | Details |
A21333 | 25400436 | World J Gastroenterol | Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. | 2014 | Details |
A21334 | 25399407 | Ital J Pediatr | Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children. | 2014 | Details |
A21336 | 25395147 | Ann Surg Oncol | Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection. | 2014 | Details |
A21338 | 25394215 | J Invest Surg | Nonalcoholic steatohepatits and liver steatosis modify partial hepatectomy recovery. | 2014 | Details |
A21340 | 25390016 | Horm Mol Biol Clin Investig | The pathophysiology of abdominal adipose tissue depots in health and disease. | 2014 | Details |
A21341 | 25389901 | Nutrients | The influence of dietary fat on liver fat accumulation. | 2014 | Details |
A21344 | 25386164 | Front Endocrinol (Lausanne) | Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. | 2014 | Details |
A21347 | 25386056 | World J Gastroenterol | MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. | 2014 | Details |
A21352 | 25382334 | Chin Med J (Engl) | Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease. | 2014 | Details |
A21355 | 25381118 | Obes Surg | Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study. | 2015 | Details |
A21357 | 25380394 | Eur J Gastroenterol Hepatol | A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes. | 2015 | Details |
A21358 | 25379859 | Ann Surg | Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. | 2014 | Details |
A21359 | 25378958 | Hepat Med | Surgical treatment of nonalcoholic fatty liver disease in severely obese patients. | 2014 | Details |
A21361 | 25376397 | Obesity (Silver Spring) | The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice. | 2014 | Details |
A21362 | 25375228 | PLoS One | Weight loss in nonalcoholic Fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits. | 2014 | Details |
A21365 | 25371775 | Oxid Med Cell Longev | Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective. | 2014 | Details |
A21366 | 25371540 | J Endocrinol | Liver immune responses to inflammatory stimuli in a diet-induced obesity model of zebrafish. | 2014 | Details |
A21370 | 25371150 | J Cell Biochem | The hepatic transcriptome of young suckling and aging intrauterine growth restricted male rats. | 2015 | Details |
A21375 | 25363574 | Clin Exp Pharmacol Physiol | Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women. | 2015 | Details |
A21380 | 25358448 | Endocrine | Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients. | 2014 | Details |
A21385 | 25356042 | World J Gastroenterol | Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. | 2014 | Details |
A21386 | 25356033 | World J Gastroenterol | ADV36 adipogenic adenovirus in human liver disease. | 2014 | Details |
A21387 | 25354830 | Dig Dis Sci | Total body weight loss of ≥ 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis. | 2014 | Details |
A21388 | 25353664 | Nutrients | Non-alcoholic fatty liver disease in children: focus on nutritional interventions. | 2014 | Details |
A21389 | 25353663 | Nutrients | Effects of dietary fat and saturated fat content on liver fat and markers of oxidative stress in overweight/obese men and women under weight-stable conditions. | 2014 | Details |
A21393 | 25352434 | Am J Physiol Endocrinol Metab | From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. | 2014 | Details |
A21396 | 25350950 | J Diabetes | Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study. | 2014 | Details |
A21399 | 25349437 | Proc Natl Acad Sci U S A | DLK1/PREF1 regulates nutrient metabolism and protects from steatosis. | 2014 | Details |
A21401 | 25348739 | J Sci Food Agric | Carnosic acid attenuates obesity-induced glucose intolerance and hepatic fat accumulation by modulating genes of lipid metabolism in C57BL/6J-ob/ob mice. | 2014 | Details |